| Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127) |
|---|
| 03/14/2013 | CA2848214A1 Production of enriched products |
| 03/13/2013 | CN202777906U Dynamic extracting tank for production of tea polyphenol |
| 03/13/2013 | CN202777843U Scraper evaporator for production of tea polyphenol |
| 03/13/2013 | CN102964330A Manufacture methods of alpha-tocopheryl and alpha-tocopheryl acetate |
| 03/13/2013 | CN102964329A Method for separating and purifying EGCG (Epigallocatechin Gallate) by medium-pressure high polymer inversed phase chromatography |
| 03/13/2013 | CN102964328A Isopentene isoflavanone compound as well as preparation method and application of compound |
| 03/13/2013 | CN102964327A Method for extracting soy isoflavone from bean pulp |
| 03/13/2013 | CN102964326A Compound with MEK (Mitogen-activated and Extracellular signal-regulated Kinase) inhibiting function as well as preparation method and application of compound |
| 03/13/2013 | CN102964322A Isoflavone or flavonoid aliphatic ether derivates, preparation method and medical application thereof |
| 03/13/2013 | CN102190646B Method for preparing high-purity quercetagetin |
| 03/13/2013 | CN102153536B Mangiferin aglycon derivative, as well as preparation method and application of the mangiferin aglycon derivative |
| 03/13/2013 | CN102153534B Compound with tyrosinase inhibitory activity as well as preparation method and application thereof |
| 03/13/2013 | CN102120946B Method for producing germ oil, oligosaccharides and protein concentrate by using soybean germs |
| 03/13/2013 | CN101130536B Flavanone compound and uses thereof |
| 03/12/2013 | US8394851 Osmoprotective complexes for prevention of mitochondrial free radical damage related skin aging |
| 03/12/2013 | US8394850 Fluorescent probe specific to hydrogen peroxide |
| 03/12/2013 | US8394794 Therapeutic compounds |
| 03/12/2013 | CA2405307C Application of substances acting as cascade inhibitors of the raf/mek/erk signaling cascade for the production of a drug against infections by dna and rna viruses |
| 03/07/2013 | WO2013033377A1 Aldh-2 inhibitors in the treatment of addiction |
| 03/07/2013 | WO2013032608A1 Indeno-fused ring compounds |
| 03/07/2013 | WO2013031831A1 Method for improving therapy for autoimmune diseases such as rheumatoid arthritis |
| 03/07/2013 | US20130059907 Wogonin-containing pharmaceutical composition for inhibiting cancer stem cells growth and application thereof |
| 03/07/2013 | US20130059384 Compositions and methods for enhancing bioenergetic status in female germ cells |
| 03/07/2013 | CA2845796A1 Aldh-2 inhibitors in the treatment of addiction |
| 03/07/2013 | CA2819537A1 Indeno-fused ring compounds |
| 03/06/2013 | CN102952109A Compound used in color composition |
| 03/06/2013 | CN102952108A Method for preparing quercetin and rhamnose by using flos sophora |
| 03/06/2013 | CN101142175B Peptidic compounds |
| 03/05/2013 | US8389745 Phosphonate fluorescent dyes and conjugates |
| 03/05/2013 | US8389568 IDO inhibitors and methods of use thereof |
| 03/05/2013 | US8388872 Photochromic materials having extended pi-conjugated systems and compositions and articles including the same |
| 02/28/2013 | WO2013026149A1 Dimethyl-(3,3-difluoro-2,2-dihydroxyheptyl)phosphonate and processes for its preparation |
| 02/28/2013 | US20130053436 Compounds, compositions and methods |
| 02/28/2013 | US20130053392 Carbonic anhydrase inhibitors |
| 02/28/2013 | US20130052237 Methods of Manufacturing Viscous Liquid Pharmaceutical Formulations |
| 02/28/2013 | CA2846264A1 Dimethyl-(3,3-difluoro-2,2-dihydroxyheptyl)phosphonate and processes for its preparation |
| 02/27/2013 | EP2562170A1 Process for production of 3-[5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2-[(3-oxo-2-substituted-2,3-dihydro-1,2-benzisoxazol-6-yl)methoxy]phenyl]propionate ester and intermediate for the process |
| 02/27/2013 | EP2560652A2 Anti-viral compounds |
| 02/27/2013 | EP2560635A2 Anti-viral compounds |
| 02/27/2013 | CN102942553A Preparation method for 6-carboxylfluorescein |
| 02/27/2013 | CN102942552A 3,11-disubstituted-14-aryl-14H-dibenzo[a,j]xanthene derivatives, preparation methods and uses thereof |
| 02/27/2013 | CN102942551A Flavanol containing 3-nitro propionyl, medical composition contain same and application thereof in pharmacy |
| 02/27/2013 | CN102942550A Method for extracting cyanidin from black bean peel |
| 02/27/2013 | CN102942549A Method for extracting blueberry anthocyanin with good stability |
| 02/27/2013 | CN102942432A Refining method of polyphenol substance and use of polyphenol substance extracted by the refining method |
| 02/27/2013 | CN102267966B Substituted benzopyrone derivatives and application thereof |
| 02/27/2013 | CN102153533B 3-nitro-2H-chromene compounds with antibacterial activity and preparation method and application thereof |
| 02/27/2013 | CN101381357B 4-bromomethyl-5,7-dihydroxy-benzopyran-2-one and synthetic method thereof and agricultural biological activity |
| 02/27/2013 | CN101265249B 4-position carbonyl nitrogen-containing derivative of 6-methoxy-4',7-dihydroxyisoflavone and medical use thereof |
| 02/26/2013 | US8383843 Method for preparing a coumarin compound, chromene compound, and method for preparing a chromene compound |
| 02/26/2013 | US8383842 Methods for purifying trans-(−)-Δ9-tetrahydrocannabinol and trans-(+)-Δ9-tetrahydrocannabinol |
| 02/26/2013 | US8383841 Phenyl xanthene dyes |
| 02/26/2013 | US8383834 Process for preparing unsaturated lactones |
| 02/26/2013 | US8383672 Halogenated rhodamine derivatives and applications thereof |
| 02/21/2013 | WO2013024779A1 Underlayer film-forming material for lithography, underlayer film for lithography, and pattern formation method |
| 02/21/2013 | WO2013024778A1 Resist composition, resist pattern formation method, polyphenol compound used therein, and alcohol compound capable of being derived therefrom |
| 02/21/2013 | WO2012065139A3 Entpd5 inhibitors |
| 02/21/2013 | US20130046082 Polar organic extract of eurycoma longifolia |
| 02/21/2013 | US20130045935 Flavonoid dimers and their use |
| 02/20/2013 | EP2558454A2 Androgen induced oxidative stress inhibitors |
| 02/20/2013 | EP2558436A1 Stabilised polyphenol derivatives, process for their manufacture, and uses thereof |
| 02/20/2013 | CN102939287A 雌激素受体调节剂及其用途 Estrogen receptor modulators and their use |
| 02/19/2013 | US8378125 Substance FKI-3864 and method for preparation thereof |
| 02/19/2013 | US8378044 Living radical polymerization method using alcohol as catalyst |
| 02/19/2013 | US8377424 Procyanidins as antineoplastic agents; topolisomerase, cylooxygenase, and/or lipoxygenase inhibitors; nitric oxide synthase modulators; hypotensive agents; treatment of gingivitis |
| 02/14/2013 | WO2013021971A1 Organic photoelectric conversion element and organic solar cell employing same |
| 02/14/2013 | WO2013020979A1 Synthesis of catechin and epicatechin conjugates |
| 02/14/2013 | WO2013020930A1 Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy |
| 02/14/2013 | WO2013020184A1 Flavonoid compounds, and methods of use thereof |
| 02/14/2013 | US20130041164 Reduction of Alpha-Tocopherol Quinone |
| 02/14/2013 | US20130040947 Trkb agonists and methods of use |
| 02/14/2013 | US20130040393 Fluorescence dye tagging scheme for mercury quantification and speciation |
| 02/14/2013 | US20130039854 Monoamine oxidase inhibitors and methods for treatment and diagnosis of prostate cancer |
| 02/14/2013 | CA2844511A1 Flavonoid compounds, and methods of use thereof |
| 02/14/2013 | CA2844275A1 Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy |
| 02/13/2013 | EP2557079A1 Synthesis of catechin and epicatechin conjugates |
| 02/13/2013 | CN102933569A Method of preparing derivatives/oligomers of epicatechin and applications thereof |
| 02/13/2013 | CN102925508A Method for preparing iridoid aglycone |
| 02/13/2013 | CN102924464A Method for separating podophyllin ester and kaempferol from podophyllum hexandrum |
| 02/13/2013 | CN102924423A Method for extracting cyanidin from banana peel |
| 02/13/2013 | CN102924422A Method for preparing oligomeric proanthocyanidins by enhanced degradation under pulsed electric field |
| 02/13/2013 | CN102924421A Preparation method and application of compound having tyrosinase inhibitory activity |
| 02/13/2013 | CN102924420A Method for extracting dihydroquercetin from root of dahurian larch |
| 02/13/2013 | CN102924419A Method for extracting fisetin from boxwood |
| 02/13/2013 | CN102924418A Method for separating and purifying effective ingredients from fine felt hairy honeysuckle |
| 02/13/2013 | CN102924417A 4-(chloromethyl)-7-hydroxy coumarin compound and preparation method thereof |
| 02/13/2013 | CN102924416A Method for separating and purifying monomeric compounds from ash bark |
| 02/13/2013 | CN102924415A 7-methoxycoumarin-3-carboxylic acid compound and preparation method thereof |
| 02/13/2013 | CN102921188A High-efficiency extraction system and extraction method of grape seed extracts |
| 02/13/2013 | CN102140087B Synthetic method for chromone compound |
| 02/13/2013 | CN102079738B Method for simultaneously preparing chemical reference substances of calycosin and formononetin |
| 02/13/2013 | CN101914097B Technological method for extracting caffeine and tea polyphenol mixture from tea step by step |
| 02/13/2013 | CN101490035B Amino-piperidine derivatives as CETP inhibitors |
| 02/12/2013 | US8372879 4-(heterocycloalkyl) benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and also in cosmetics |
| 02/12/2013 | CA2479123C Dihydronepetalactone as insect repellent |
| 02/07/2013 | WO2013019686A2 Novel semi-synthetic small molecules for the treatment parasitic disease |
| 02/07/2013 | WO2013018104A2 Extraction of vitamin e from plant matter |
| 02/07/2013 | WO2013018053A1 Process for the preparation of epoxides as intermediates for the synthesis of nebivolol |
| 02/07/2013 | WO2013017071A1 Alicyclic[c] benzopyrone derivatives and uses thereof |
| 02/07/2013 | WO2013017068A1 Substituted benzopyrone derivative and use thereof |